Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Cell Biol ; 177(6): 1119-32, 2007 Jun 18.
Artigo em Inglês | MEDLINE | ID: mdl-17576803

RESUMO

Clearance of fibrin through proteolytic degradation is a critical step of matrix remodeling that contributes to tissue repair in a variety of pathological conditions, such as stroke, atherosclerosis, and pulmonary disease. However, the molecular mechanisms that regulate fibrin deposition are not known. Here, we report that the p75 neurotrophin receptor (p75(NTR)), a TNF receptor superfamily member up-regulated after tissue injury, blocks fibrinolysis by down-regulating the serine protease, tissue plasminogen activator (tPA), and up-regulating plasminogen activator inhibitor-1 (PAI-1). We have discovered a new mechanism in which phosphodiesterase PDE4A4/5 interacts with p75(NTR) to enhance cAMP degradation. The p75(NTR)-dependent down-regulation of cAMP results in a decrease in extracellular proteolytic activity. This mechanism is supported in vivo in p75(NTR)-deficient mice, which show increased proteolysis after sciatic nerve injury and lung fibrosis. Our results reveal a novel pathogenic mechanism by which p75(NTR) regulates degradation of cAMP and perpetuates scar formation after injury.


Assuntos
3',5'-AMP Cíclico Fosfodiesterases/metabolismo , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , AMP Cíclico/metabolismo , Fibrose , Receptor de Fator de Crescimento Neural/fisiologia , Ativador de Plasminogênio Tecidual/antagonistas & inibidores , Animais , Cicatriz/etiologia , Nucleotídeo Cíclico Fosfodiesterase do Tipo 4 , Fibrinólise , Regulação da Expressão Gênica , Camundongos , Camundongos Knockout , Inibidor 1 de Ativador de Plasminogênio/genética , Nervo Isquiático/lesões , Ferimentos e Lesões
2.
Oncotarget ; 5(13): 4990-5001, 2014 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-24970801

RESUMO

Diffuse large B cell lymphoma is generally treated by chemotherapy and there is an unmet medical need for novel targeted therapies or combination therapies. Using in vitro screening, we have identified the combination of ibrutinib, an inhibitor of the tyrosine kinase BTK, and AZD2014, an mTOR catalytic inhibitor, as being highly synergistic in killing ABC-subtype DLBCL cell lines. Simultaneous inhibition of BTK and mTOR causes apoptosis both in vitro and in vivo and results in tumor regression in a xenograft model. We identify two parallel mechanisms that underlie apoptosis in this setting: cooperative inhibition of cap-dependent translation, and the inhibition of an NF-κB/IL10/STAT3 autocrine loop. Combined disruption of these pathways is required for apoptosis. These data represent a rational basis for the dual inhibition of BTK and mTOR as a potential treatment for ABC-subtype DLBCL.


Assuntos
Apoptose/efeitos dos fármacos , Linfoma Difuso de Grandes Células B/tratamento farmacológico , Complexos Multiproteicos/antagonistas & inibidores , Inibidores de Proteínas Quinases/farmacologia , Proteínas Tirosina Quinases/antagonistas & inibidores , Serina-Treonina Quinases TOR/antagonistas & inibidores , Adenina/análogos & derivados , Tirosina Quinase da Agamaglobulinemia , Animais , Benzamidas , Western Blotting , Linhagem Celular Tumoral , Relação Dose-Resposta a Droga , Sinergismo Farmacológico , Feminino , Células HEK293 , Humanos , Interleucina-10/genética , Interleucina-10/metabolismo , Linfoma Difuso de Grandes Células B/genética , Linfoma Difuso de Grandes Células B/metabolismo , Alvo Mecanístico do Complexo 1 de Rapamicina , Alvo Mecanístico do Complexo 2 de Rapamicina , Camundongos SCID , Morfolinas/farmacologia , Complexos Multiproteicos/genética , Complexos Multiproteicos/metabolismo , NF-kappa B/genética , NF-kappa B/metabolismo , Piperidinas , Proteínas Tirosina Quinases/genética , Proteínas Tirosina Quinases/metabolismo , Pirazóis/farmacologia , Pirimidinas/farmacologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fator de Transcrição STAT3/genética , Fator de Transcrição STAT3/metabolismo , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/genética , Serina-Treonina Quinases TOR/genética , Serina-Treonina Quinases TOR/metabolismo , Transcriptoma/efeitos dos fármacos , Carga Tumoral/efeitos dos fármacos , Carga Tumoral/genética , Ensaios Antitumorais Modelo de Xenoenxerto
3.
Cell Cycle ; 10(11): 1764-71, 2011 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-21555919

RESUMO

Scar formation inhibits tissue repair and regeneration in the liver and central nervous system. Activation of hepatic stellate cells (HSCs) after liver injury or of astrocytes after nervous system damage is considered to drive scar formation. HSCs are the fibrotic cells of the liver, as they undergo activation and acquire fibrogenic properties after liver injury. HSC activation has been compared to reactive gliosis of astrocytes, which acquire a reactive phenotype and contribute to scar formation after nervous system injury, much like HSCs after liver injury. It is intriguing that a wide range of neuroglia-related molecules are expressed by HSCs. We identified an unexpected role for the p75 neurotrophin receptor in regulating HSC activation and liver repair. Here we discuss the molecular mechanisms that regulate HSC activation and reactive gliosis and their contributions to scar formation and tissue repair. Juxtaposing key mechanistic and functional similarities in HSC and astrocyte activation might provide novel insight into liver regeneration and nervous system repair.


Assuntos
Astrócitos/fisiologia , Cicatriz/patologia , Células Estreladas do Fígado/fisiologia , Cicatrização , Animais , Humanos , Regeneração Hepática , Regeneração Nervosa
4.
Science ; 315(5820): 1853-6, 2007 Mar 30.
Artigo em Inglês | MEDLINE | ID: mdl-17395831

RESUMO

Differentiation of hepatic stellate cells (HSCs) to extracellular matrix- and growth factor-producing cells supports liver regeneration through promotion of hepatocyte proliferation. We show that the neurotrophin receptor p75NTR, a tumor necrosis factor receptor superfamily member expressed in HSCs after fibrotic and cirrhotic liver injury in humans, is a regulator of liver repair. In mice, depletion of p75NTR exacerbated liver pathology and inhibited hepatocyte proliferation in vivo. p75NTR-/- HSCs failed to differentiate to myofibroblasts and did not support hepatocyte proliferation. Moreover, inhibition of p75NTR signaling to the small guanosine triphosphatase Rho resulted in impaired HSC differentiation. Our results identify signaling from p75NTR to Rho as a mechanism for the regulation of HSC differentiation to regeneration-promoting cells that support hepatocyte proliferation in the diseased liver.


Assuntos
Diferenciação Celular , Fibroblastos/citologia , Hepatócitos/citologia , Hepatopatias/patologia , Regeneração Hepática , Fígado/citologia , Receptores de Fator de Crescimento Neural/metabolismo , Animais , Proliferação de Células , Células Cultivadas , Progressão da Doença , Matriz Extracelular/metabolismo , Fator de Crescimento de Hepatócito/metabolismo , Fígado/metabolismo , Fígado/patologia , Fígado/fisiologia , Hepatopatias/metabolismo , Camundongos , Fator de Crescimento Neural/farmacologia , Receptores de Fator de Crescimento Neural/genética , Transdução de Sinais , Proteínas rho de Ligação ao GTP/metabolismo
5.
Mol Interv ; 4(3): 163-76, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15210870

RESUMO

In brain physiology, cerebrovascular interactions regulate both, vascular functions, such as blood vessel branching and endothelial cell homeostasis, as well as neuronal functions, such as local synaptic activity and adult neurogenesis. In brain pathology, including stroke, HIV encephalitis, Alzheimer Disease, multiple sclerosis, bacterial meningitis, and glioblastomas, rupture of the vasculature allows the entry of blood proteins into the brain with subsequent edema formation and neuronal damage. Fibrin is a blood-derived protein that is not produced by cells of the nervous system, but accumulates only after disease associated with vasculature rupture. This review presents evidence from human disease and animal models that highlight the role of fibrin in nervous system pathology. Our review presents novel experimental data that extend the role of fibrin, from that of a blood-clotting protein in cerebrovascular pathologies, to a component of the perivascular extracellular matrix that regulates inflammatory and regenerative cellular responses in neurodegenerative diseases.


Assuntos
Barreira Hematoencefálica , Fibrina/metabolismo , Sistema Nervoso , Sequência de Aminoácidos , Ancrod/genética , Ancrod/metabolismo , Animais , Barreira Hematoencefálica/metabolismo , Barreira Hematoencefálica/patologia , Barreira Hematoencefálica/ultraestrutura , Fibrinogênio/metabolismo , Fibrinolíticos/metabolismo , Homeostase , Humanos , Inflamação/metabolismo , Inflamação/patologia , Macrófagos/metabolismo , Dados de Sequência Molecular , Esclerose Múltipla/imunologia , Esclerose Múltipla/patologia , Bainha de Mielina/metabolismo , Regeneração Nervosa/fisiologia , Sistema Nervoso/irrigação sanguínea , Sistema Nervoso/metabolismo , Sistema Nervoso/patologia , Neuroglia/citologia , Neuroglia/metabolismo , Neurônios/citologia , Neurônios/metabolismo , Transdução de Sinais/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA